MWNA
ONSIZ

Marshall Wace North America’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Marshall Wace North America’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-125,100
Closed -$6K – 1922
2018
Q1 		$6K Hold
125,100
– – ﹤0.01% 1391
2017
Q4 		$3K Hold
125,100
– – ﹤0.01% 1335
2017
Q3 		$0 Hold
125,100
– – ﹤0.01% 1671
2017
Q2 		$0 Hold
125,100
– – ﹤0.01% 1547
2017
Q1 		$125K Buy
+125,100
New +$54.1K ﹤0.01% 933

Marshall Wace North America's ONSIZ Position: Q2 2018 in Review

Marshall Wace North America sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q2 2018, closing a stake of 125,100 shares — an estimated $6K sold.

Marshall Wace North America first reported a position in ONSIZ in Q1 2017 and held it in 5 quarters. The position peaked at $125K in Q1 2017. 0 funds tracked by Wall St. Rank hold ONSIZ as of Q2 2018.

  • Marshall Wace North America reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q2 2018 after selling out during the quarter.
  • Marshall Wace North America sold 125,100 Oncobiologics, Inc. Series B Warrant shares in Q2 2018, an estimated $6K.
  • Marshall Wace North America first reported a position in Oncobiologics, Inc. Series B Warrant in Q1 2017 and held it in 5 quarters.
  • Marshall Wace North America's Oncobiologics, Inc. Series B Warrant position peaked at $125K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q2 2018.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.